Point of Care Tests

Our interdisciplinary team of chemists, biologists and engineers work closely with key opinion leaders and external SMEs to develop rapid diagnostic tests and assays designed for end users in the field, clinical offices and hospital bedsides.

Zymeron’s POC test kits include a portable or handheld reader and single-use immunoassay or aptamer-based assay cartridges. The sample collector and assay cartridge are integrated in one self-contained device for easy use, convenient handling and minimized operator steps. The test achieves enhanced sensitivity comparable to laboratory immunoassays (i.e. ELISA and microparticle EIAs) through the use of fluorescent nanoprobes. Our rapid POC tests overcome the drawbacks (i.e. low sensitivity) of conventional paper-based assays while taking advantage of their many inherent attributes as an ideal rapid, low-cost, and point-of-care test format. We have developed different device configurations to handle singleplex or multiplex analytes from a broad range of clinical, veterinary, forensic and environmental samples including contaminated water, blood, plasma, urine, saliva, swabs and digestible tissues.

Highly Accurate.

  • Highly advanced testing in a point-of-care setting.
  • Excellent results agreement with laboratory tests.
  • Reader improves usability and reduces user subjectivity and errors.
  • Quantitative or qualitative.

Easy & Fast.

  • Using Zymeron’s POC tests is easy and fast (15-20 min).
  • All reagents are pre-stored on-board allowing three simple user-friendly steps: insert-twist-push to complete from sample collection to results display.


  • Truly point-of-care testing.
  • Use a compact reader with light weight and minimal footprint.
  • Broad operating temperatures and humidity.
  • Rugged transit case for field use.

POCT Product Pipeline

Our product development and commercialization use flexible process but follow the same basic principles. It starts with market research to identify end user needs, design product concept, conduct feasibility studies, assay optimization, design verification, system integration, and clinical validation. Zymeron’s POCT program focuses on infectious disease monitoring and emergent threat agent detection.

Technology Highlight – Rapid Point-Of-Care Tests using a Novel Assay Format to Differentiate All Flavivirus Infections From Each Other. The assay  achieved 100% specificity (zero false positive) for the serostatus of Dengue, ZIKA, West Nile, or any other flavivirus infection. Download the technology whitepaper.

A product pipeline
Z102 Cytomegalovirus (CMV) Serostatus
Z108 Antibiotic Therapeutic Drug Monitoring
Z116 Opioid Colorimetric Assay